Stock HPHA HEIDELBERG PHARMA AG
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Heidelberg Pharma AG Deutsche Boerse AG

Equities

HPHA

DE000A11QVV0

Real-time Estimate Tradegate
Other stock markets
 05:30:00 2024-07-16 am EDT 		5-day change 1st Jan Change
2.585 EUR +1.77% Intraday chart for Heidelberg Pharma AG 0.00% -29.86%
Jul. 11 Heidelberg Pharma AG Reports Earnings Results for the Half Year Ended May 31, 2024 CI
Apr. 25 Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Heidelberg Pharma : Half-year financial report 2024
PU
Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
EQ
Heidelberg Pharma reports on the results of the Annual General Meeting 2024
EQ
AH: Heidelberg Pharma AG announces update of forecast
AQ
Heidelberg Pharma AG announces updated guidance
EQ
Heidelberg Pharma : Revocation of proxy
PU
Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024
EQ
Heidelberg Pharma : Agenda and convening of the general meeting (published in Bundesanzeiger on 13 May 2024)
PU
Heidelberg Pharma : Report of the Management Board on agenda item 5
PU
Heidelberg Pharma : Aktuelle Unternehmenspräsentation, Mai 2024
PU
Heidelberg Pharma : Current Company Presentation, May 2024
PU
Heidelberg Pharma : Remuneration Report 2023
PU
Heidelberg Pharma : Remuneration report for the financial year 2022/2023 including audit opinion
PU
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024
EQ
DD: Heidelberg Pharma AG: Walter Miller, buy
EQ
Heidelberg Pharma to host R&D Webinar following novel data presented at AACR
EQ
PM: Heidelberg Pharma receives Orphan Drug Designation from the FDA for its ATAC candidate HDP-101
AQ
Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101
EQ
DD: Heidelberg Pharma AG: Dr. Georg F. Baur, buy
EQ
Heidelberg Pharma : Presentation Analyst and Press Conference 2024
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HPHA Stock
  4. HPHA Stock
  5. News Heidelberg Pharma AG
  6. Press Releases